Mannkind Corp

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.44

-0.06 (-1.71%)

As of Sep 22, 1:40 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +818.9% upside

Low Target $20.51

Average Target $31.61

High Target $34.61

Current Price $3.44

Current
$3.44

Target
$31.61

$20.51 $31.61 avg $34.61

Scenario Analysis

Bear Case

$20.51

496.2%

Low target

Base Case

$31.61

+818.9%

Avg target

Bull Case

$34.61

+906.1%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$6.51

-47.2% from high

52-Week Low

$2.23

+54.3% from low

Target vs 52W High

$31.61

+385.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%